Analysts expect CoreCivic, Inc. (NYSE:CXW) to report $0.63 EPS on August, 14.They anticipate $0.06 EPS change or 10.53 % from last quarter’s $0.57 EPS. CXW’s profit would be $75.02M giving it 7.12 P/E if the $0.63 EPS is correct. After having $0.64 EPS previously, CoreCivic, Inc.’s analysts see -1.56 % […]
Analysts expect Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) to report $-0.22 EPS on August, 14.They anticipate $0.01 EPS change or 4.76 % from last quarter’s $-0.21 EPS. After having $-0.43 EPS previously, Corbus Pharmaceuticals Holdings, Inc.’s analysts see -48.84 % EPS growth. The stock decreased 1.06% or $0.07 during the last […]
Analysts expect BioXcel Therapeutics, Inc. (NASDAQ:BTAI) to report $-0.52 EPS on August, 14.They anticipate $0.33 EPS change or 173.68 % from last quarter’s $-0.19 EPS. After having $-0.46 EPS previously, BioXcel Therapeutics, Inc.’s analysts see 13.04 % EPS growth. The stock decreased 0.96% or $0.1 during the last trading session, […]
Analysts expect Adverum Biotechnologies, Inc. (NASDAQ:ADVM) to report $-0.30 EPS on August, 14.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.3 EPS. After having $-0.23 EPS previously, Adverum Biotechnologies, Inc.’s analysts see 30.43 % EPS growth. The stock increased 3.27% or $0.49 during the last trading session, […]
Analysts expect Park Lawn Corporation (TSE:PLC) to report $0.24 EPS on August, 13.They anticipate $0.06 EPS change or 33.33 % from last quarter’s $0.18 EPS. T_PLC’s profit would be $6.90M giving it 30.09 P/E if the $0.24 EPS is correct. After having $0.22 EPS previously, Park Lawn Corporation’s analysts see […]
Investors sentiment decreased to 0.44 in Q1 2019. Its down 0.56, from 1 in 2018Q4. It dived, as 2 investors sold Sophiris Bio, Inc. shares while 7 reduced holdings. 2 funds opened positions while 2 raised stakes. 2.48 million shares or 3.17% less from 2.56 million shares in 2018Q4 were […]
Analysts expect OncoCyte Corporation (NYSEAMERICAN:OCX) to report $-0.10 EPS on August, 13.They anticipate $0.02 EPS change or 16.67 % from last quarter’s $-0.12 EPS. After having $-0.08 EPS previously, OncoCyte Corporation’s analysts see 25.00 % EPS growth. The stock increased 7.35% or $0.15 during the last trading session, reaching $2.19. […]
Analysts expect Motus GI Holdings, Inc. (NASDAQ:MOTS) to report $-0.30 EPS on August, 13.They anticipate $0.03 EPS change or 11.11 % from last quarter’s $-0.27 EPS. After having $-0.29 EPS previously, Motus GI Holdings, Inc.’s analysts see 3.45 % EPS growth. The stock decreased 2.24% or $0.07 during the last […]
